The Georgia Regents University Cancer Center is leading a group of Southeastern hospitals in implementing a new treatment protocol for acute promyelocytic leukemia, a rare and potentially fatal illness that can limit coagulation and induce severe bleeding. The five-center effort has received a $1.67 million, five-year grant. The protocol includes treatment with all-trans-retinoic acid and blood transfusions.

Related Summaries